Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - Asian Market Preview: Nikkei Futures (1.28%), Hang Seng Futures (0.44%), ASX SPI 200 (0.35%), S&P Futures +0.15%

Jan 20 ,2026

  • Synopsis:

    • Asian markets set for negative start to Wednesday trade. Futures signaling opening declines in Japan and Hong Kong. ASX lower in initial trade. S&P 500 futures edging higher after index experienced biggest daily loss since October. Australian bonds little changed after JGB yield backup reverberated globally on Monday with Treasuries under pressure. FX markets steady after dollar skidded to two-week low. Crude reversing earlier gains while gold unchanged after rallying to fresh record high. Bitcoin flat after erasing most of its January gains.

    • JGB selloff the big market story superlong yields spiked to record highs with intraday moves the largest since 'Liberation Day' in Apr-2024. Blame went largely to PM Takaichi's recent comments about temporarily reducing food sales tax to zero, heightening market angst about implications for deficits from an increasingly expansionary fiscal policy and inviting comparisons to Truss shock in 2022. Concerns about tepid demand underlined further by Tuesday's weak 20Y auction. Volatility prompted Finance Minister Katayama to urge calm and stress that government will weigh options to fund tax cuts.

    • Market continues to navigate ramp in trade tensions following President Trump's threat to impose tariffs on EU unless Denmark hands over Greenland, reviving 'sell America' trade with stocks, bonds and dollar all under pressure. Trump not backing down and predicted things will work out while refusing to divulge lengths he will go to acquire Greenland. There continues to be a lot of discussion about potential European countermeasures (tariffs and anti-coercion instrument), though accompanied by talk about off ramps that will avert worst-case scenario amid view tariff threat tantamount to another 'escalate-to-deescalate' strategy.

  • Pre-open Company News:

    • 000720.KS -- HYUNDAI ENGINEERING & CONSTRUCTION CO. now guides EBIT KRW650.0B vs prior guidance KRW1.183T and FactSet KRW641.81B [19 est, KRW571.50-693.72B]

    • 533179.IN -- Persistent Systems reports Q3 consolidated EPS INR27.94 vs year-ago INR23.93

    • 000729.CH -- Beijing Yanjing Brewery guides FY net income attributable CNY1.58-1.74B vs FactSet CNY1.56B [14 est, CNY1.43-1.61B]

    • 541770.IN -- CreditAccess Grameen reports Q3 consolidated net income INR2.52B vs FactSet INR2.38B [6 est, INR2.09-2.61B]

    • 544606.IN -- Pine Labs unit Setu receives RBI approval to acquire remaining stake in Agya Technologies, terms undisclosed

    • 540611.IN -- AU Small Finance Bank reports Q3 EPS INR8.87 vs FactSet INR8.78 [5 est, INR8.30-9.40]

    • China December air passenger traffic 60.6M, +6.4% y/y

    • 532209.IN -- Jammu & Kashmir Bank reports Q3 consolidated EPS INR5.28 vs year-ago INR4.80

    • 523367.IN -- DCM Shriram reports Q3 consolidated EPS ex-items INR15.90 vs year-ago INR16.81

    • COGT -- Cogent to initiate NDA submission for Bezuclastinib under Real-Time Oncology Review (RTOR)

    • 600098.CH -- Guangzhou Development Group reports Q3 total power generation 5.46B kWh, +3.0% y/y

    • 543248.IN -- Aayush Agrawal's Inspira Global to acquire Restaurant Brands Asia at INR70/share

    • 688050.CH -- Eyebright Medical Technology (Beijing) to acquire 51% stake in Delta Medical (Chongqing)

    • 1672.HK -- Ascletis Pharma selects ASC37 as clinical development candidate for treatment of obesity

    • 542726.IN -- IndiaMART InterMESH reports Q3 consolidated EPS INR31.24 vs FactSet INR20.84 [7 est, INR16.30-25.30]

  • On Deck:

    • China:

      • Economic:

        • 08:00 CST: Foreign Direct Investment Y/Y; consensus

    • Japan:

      • Earnings:

        • DISCO Corp. (6146.JP)

    • South Korea:

      • Earnings:

        • Samsung Biologics (207940.KS)

    • India:

      • Earnings:

        • Vardhman Textiles (502986.IN), Supreme Industries (509930.IN), UTI Asset Management (543238.IN), Oracle Financial Services Software (532466.IN), Hindustan Petroleum (500104.IN), KEI Industries (517569.IN), Jindal Stainless (532508.IN), PNB Housing Finance (540173.IN), WAAREE Energies (544277.IN)

  • Market Data:

    • Gold (Feb 26): ($2.20) or (0.05%) to $4763.60

    • WTI Crude (Feb 26): $0.00 or 0.00% to $60.34

    • $-¥: +0.08 or +0.05% to 158.1520

    • $-KRW: +4.22 or +0.29% to 1477.7800

    • A$-$: +0.01 or +0.75% to 0.6733

    • $-INR: +0.41 or +0.46% to 91.1183

    • $-CNY: (0.01) or (0.12%) to 6.9602

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE